DANA HARDEN: Open Payments
NPI 1427328236 · MILFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,571 in 86 payments from 20 companies in 2025. Trend: 2023 $1,597 · 2024 $2,233 · 2025 $1,571
Food & beverage: $1,571
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 51 | $649 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $172 |
| Galderma Laboratories, L.P. | 2 | $123 |
| Exact Sciences Corporation | 4 | $89 |
| AstraZeneca Pharmaceuticals LP | 4 | $79 |
| PFIZER INC. | 4 | $68 |
| Inspire Medical Systems, Inc. | 2 | $68 |
| Esperion Therapeutics, Inc. | 2 | $58 |
| Novo Nordisk Inc | 2 | $51 |
| Axsome Therapeutics, Inc. | 2 | $39 |
Products named: VRAYLAR, JARDIANCE, UBRELVY, QULIPTA, INSPIRE, NEXLETOL, NURTEC ODT, Wegovy.
Industry payments across CT — which companies pay providers there.
